Differences

This shows you the differences between two versions of the page.

--- helen_rees [2022/06/06 16:53]
liam
+++ helen_rees [2022/12/13 17:44] (current)
pamela [Sabin-Aspen Vaccine Science & Policy Group]
@@ Line 44: / Line 44: @@
 ==== GE2P2 Global Foundation ====
-Rees delivered a keynote presentation at the 2011 [[Global Vaccines 202X Access, Equity, Ethics Symposium]] titled WHO’s Immunization Policy Framework: Is it achieving its goal? She was introduced to the audience by [[Paul Offit]]. The symposium was hosted by the [[Center for Vaccine Ethics and Policy]] (CVEP), a program of the [[GE2P2 Global Foundation]]. Rees is a fellow of the foundation.
+Rees delivered a keynote presentation at the 2011 [[Global Vaccines 202X Access, Equity, Ethics Symposium]] titled WHO’s Immunization Policy Framework: Is it achieving its goal?((Curry, D. R. (2011, May 16). //Symposium – Global Vaccines 202X: Access, Equity, Ethics.// Center for Vaccine Ethics and Policy. https://archive.ph/zgDxl)) She was introduced to the audience by [[Paul Offit]]. The symposium was hosted by the [[Center for Vaccine Ethics and Policy]] (CVEP), a program of the [[GE2P2 Global Foundation]].((Curry, D. R. (2009, March 2). //About us.// Center for Vaccine Ethics and Policy. https://centerforvaccineethicsandpolicy.net/about/ )) Rees is a fellow of the foundation.((//Helen Rees, MD, OBE.// (2019, February 19). GE2P2 Global Foundation. https://archive.ph/MEZpD))
-The GE2P2 Global Foundation is supported by the [[Alliance for Regenerative Medicine]], a consortium of [[gene therapy]] [[pharmaceutical companies]] including [[pharmaceutical_companies:Astellas]], [[pharmaceutical_companies:Bristol-Myers Squibb]], [[pharmaceutical_companies:CRISPR Therapeutics]], [[pharmaceutical_companies:CSL]], [[pharmaceutical_companies:Fresenius Kabi]], [[medical_technology_companies:GE Healthcare]], [[pharmaceutical_companies:Gilead Sciences]] (through [[pharmaceutical_companies:Kite Pharma]]), [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Johnson & Johnson]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Novo Nordisk]], [[pharmaceutical_companies:Oxford Biomedica]], [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Sanofi]], [[pharmaceutical_companies:Spark Therapeutics]], [[pharmaceutical_companies:Takeda, Terumo]], and [[medical_technology_companies:Thermo Fisher Scientific]].
+The GE2P2 Global Foundation is supported by the [[Alliance for Regenerative Medicine]], a consortium of [[gene therapy]] [[pharmaceutical companies]] including [[pharmaceutical_companies:Astellas]], [[pharmaceutical_companies:Bristol-Myers Squibb]], [[pharmaceutical_companies:CRISPR Therapeutics]], [[pharmaceutical_companies:CSL]], [[pharmaceutical_companies:Fresenius Kabi]], [[medical_technology_companies:GE Healthcare]], [[pharmaceutical_companies:Gilead Sciences]] (through [[pharmaceutical_companies:Kite Pharma]]), [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Johnson & Johnson]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Novo Nordisk]], [[pharmaceutical_companies:Oxford Biomedica]], [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Sanofi]], [[pharmaceutical_companies:Spark Therapeutics]], [[pharmaceutical_companies:Takeda, Terumo]], and [[medical_technology_companies:Thermo Fisher Scientific]].((//Advancing Gene, Cell, & Tissue-Based Therapies.// Alliance for Regenerative Medicine. Retrieved June 3, 2022, from https://alliancerm.org/sector-report/2019-annual-report))
 ==== Gavi, the Vaccine Alliance ====
@@ Line 54: / Line 54: @@
 ==== Population Council ====
-Rees serves as a technical expert for the [[Population Council]].
+Rees serves as a technical expert for the [[Population Council]].((//Professor Helen Rees.// (2016, May 25). Murray Edwards College - University of Cambridge. https://archive.ph/1hjWJ))
-The Population Council was founded by the [[Rockefeller]] family and is rooted in [[eugenics]]. Its first president, [[Frederick Osborn]], was a former head of the [[American Eugenics Society]]. In its 1957 Annual Report, the council explains that “the Council is increasingly in a position to contribute to the understanding and so, perhaps, to the solution of problems of world population growth and change.” The council runs its [[Center for Biomedical Research]] (CBR) out of [[Rockefeller University]] in [[united_states_of_america:New York]].
-The Population Council has a history of funding from [[pharmaceutical_companies:Bayer]], the [[Bill & Melinda Gates Foundation]], the [[Ford Foundation]], [[KPMG]], the [[Markle Foundation]], and the [[National Institutes of Health]] (NIH).
-Its Board of Trustees has included representatives from [[AT&T]], the [[Atomic Energy Commission]], [[Brown University]], the [[Carnegie Institution of Washington]], [[Chase Manhattan Bank]], [[Columbia-Presbyterian Medical Center]], [[General Electric Company]], [[Harvard University]], the [[Milbank Memorial Fund]], [[Mt. Sinai Hospital]], the [[Rockefeller Institute]], and [[Scripps Foundation for Research in Population Problems]].
-In 2015, the council convened a meeting on quality of care sponsored by the [[Packard Foundation]], and attended by representatives from [[Abt Associates]], [[Family Planning 2020]], [[Harvard T.H. Chan School of Public Health]], [[Ibis Reproductive Health]], [[ICF International]], [[Jhpiego]], [[Johns Hopkins Bloomberg School of Public Health]], [[MSI Reproductive Choices]], [[O’Hanlon Health Consulting]], [[Population Action International]], [[PSI]], [[United Nations Population Fund]] (UNFPA), [[University of North Carolina]], and the [[World Health Organization]].
 ==== South African Health Products Regulatory Authority (SAHPRA) ====
-Rees is chair of the [[South African Health Products Regulatory Authority]] (SAHPRA) Board. SAHPRA is the organization in charge of regulating the use of all health products throughout South Africa, including [[COVID-19 vaccines]]. Rees oversaw the approval of the injections from [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Johnson & Johnson]], and [[pharmaceutical_companies:AstraZeneca]].
+Rees is chair of the [[South African Health Products Regulatory Authority]] (SAHPRA) Board.((//The SAHPRA Board.// (2022). SAHPRA. https://archive.ph/G7xmz)) SAHPRA is the organization in charge of regulating the use of all health products throughout South Africa, including [[COVID-19 vaccines]].((//SAHPRA update on Vaccine Approvals.// (2021, June 21). SAHPRA. https://archive.ph/krWIz)) Rees oversaw the approval of the injections from [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Johnson & Johnson]], and [[pharmaceutical_companies:AstraZeneca]].
 ==== National Institute of Communicable Diseases ====
@@ Line 74: / Line 65: @@
 ==== Coalition for Epidemic Preparedness Innovations ====
-Rees is Chair of the Scientific Advisory Board of the [[Coalition for Epidemic Preparedness Innovations]] (CEPI).
+Rees is Chair of the Scientific Advisory Board of the [[Coalition for Epidemic Preparedness Innovations]] (CEPI).((Gutierrez, Jr., O. R. (2020, June 29). //Partnership science.// POZ. https://archive.ph/mKx1V))
 ==== International AIDS Vaccine Initiative ====
-Rees is a member of the Board of the [[International AIDS Vaccine Initiative]] (IAVI).
+Rees is a member of the Board of the [[International AIDS Vaccine Initiative]] (IAVI).((//Professor Helen Rees (Chairperson).// (2013, October 7). World Health Organization. https://web.archive.org/web/20200909093333/https://www.who.int/immunization/sage/members/bio_rees/en/))
 ==== Sabin-Aspen Vaccine Science & Policy Group ====
-Rees is a member of the [[Sabin-Aspen Vaccine Science & Policy Group]], an initiative of the S[[abin Vaccine Institute]] and the [[Aspen Institute]]. The group is funded by the [[Bill & Melinda Gates Foundation]] and [[Wellcome Trust]].
+Rees is a member of the [[:Sabin-Aspen Vaccine Science & Policy Group]], an initiative of the S[[abin Vaccine Institute]] and the [[:Aspen Institute]].((//The Group.// The Sabin-Aspen Vaccine Science & Policy Group. Retrieved June 5, 2022, from https://archive.ph/WqVzI)) The group is funded by the [[:Bill & Melinda Gates Foundation]] and [[Wellcome Trust]].
 ==== Ministerial Advisory Committee on COVID-19 and Vaccines ====
-Rees is a member of the [[Ministerial Advisory Committee on COVID-19]], and a member of the [[Ministerial Advisory Committee on COVID-19 vaccines]].
+Rees is a member of the [[Ministerial Advisory Committee on COVID-19]],((//Ministerial Advisory Committees on COVID-19// (pp. 4, 8). (2020). Bhekisisa Centre for Health Journalism. https://web.archive.org/web/20220303122616/https://bhekisisa.org/wp-content/uploads/2020/05/38bf41e2-ministerial-advisory-committees-on-covid-19.pdf)) and a member of the [[Ministerial Advisory Committee on COVID-19 vaccines]].((SABC News. (2021, August 22). //Focus on the COVID-19 vaccines with Professor Helen Rees.// YouTube. https://web.archive.org/web/20220603233806/https://www.youtube.com/watch?v=T9pJL_u6wog)) ((Witz RHI. (2022, March 9). //French National Order of Merit awarded to Professor Helen Rees - Wits University.// University of the Witwatersrand, Johannesburg. https://archive.ph/nQTlU))
 ==== COVID-19 Clinical Research Coalition ====
-Rees is a member of the Steering Committee of the [[COVID-19 Clinical Research Coalition]].
+Rees is a member of the Steering Committee of the [[COVID-19 Clinical Research Coalition]].((//Helen Rees.// COVID-19 Clinical Research Coalition. Retrieved June 3, 2022, from https://archive.ph/pBgkH))
-The coalition was co-launched and is hosted by the [[Drugs for Neglected Diseases initiative]] (DNDi), which is partnered with a very large number of [[pharmaceutical companies]] including [[pharmaceutical_companies:Astellas]], [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Bayer]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[pharmaceutical_companies:Bristol-Myers Squibb]], [[pharmaceutical_companies:Genzyme]], [[pharmaceutical_companies:Gilead Sciences]], [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Janssen]], [[pharmaceutical_companies:Johnson & Johnson]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Roche]], [[pharmaceutical_companies:Sanofi]], [[pharmaceutical_companies:Takeda]], [[medical_technology_companies:Thermo Fisher Scientific]], [[pharmaceutical_companies:Vertex]], [[pharmaceutical_companies:Viatris]], and [[pharmaceutical_companies:Zoetis]].
+The coalition was co-launched and is hosted by the [[Drugs for Neglected Diseases initiative]] (DNDi),((//Donors.// COVID-19 Clinical Research Coalition. Retrieved June 3, 2022, from https://archive.ph/OAJwb)) which is partnered with a very large number of [[pharmaceutical companies]] including [[pharmaceutical_companies:Astellas]], [[pharmaceutical_companies:AstraZeneca]], [[pharmaceutical_companies:Bayer]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[pharmaceutical_companies:Bristol-Myers Squibb]], [[pharmaceutical_companies:Genzyme]], [[pharmaceutical_companies:Gilead Sciences]], [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Janssen]], [[pharmaceutical_companies:Johnson & Johnson]], [[pharmaceutical_companies:Merck]], [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Pfizer]], [[pharmaceutical_companies:Roche]], [[pharmaceutical_companies:Sanofi]], [[pharmaceutical_companies:Takeda]], [[medical_technology_companies:Thermo Fisher Scientific]], [[pharmaceutical_companies:Vertex]], [[pharmaceutical_companies:Viatris]], and [[pharmaceutical_companies:Zoetis]].((//Industry partners and service providers.// DNDi. Retrieved June 3, 2022, from https://archive.ph/28sJH))
-Other partners include the [[Bill & Melinda Gates Foundation]], the [[Global Fund]], [[Horizon 2020]], [[Imperial College London]], [[Institut Pasteur]], [[London School of Hygiene and Tropical Medicine]], [[McGill University]], [[National Institute of Allergy and Infectious Diseases]] (NIAID), [[National Institutes of Health]], [[Pan-American Health Organization]] (PAHO), [[PATH]], [[Rockefeller Foundation]], [[Task Force for Global Health]], [[UKaid]], US [[Food and Drug Administration]], the [[United States Navy]], [[Unitaid]], [[University of Washington]], [[United States Agency for International Development]], [[Wellcome Trust]], and the [[World Health Organization]].
+Other partners include the [[Bill & Melinda Gates Foundation]], the [[Global Fund]], [[Horizon 2020]], [[Imperial College London]], [[Institut Pasteur]], [[London School of Hygiene and Tropical Medicine]], [[McGill University]], [[National Institute of Allergy and Infectious Diseases]] (NIAID), [[National Institutes of Health]], [[Pan-American Health Organization]] (PAHO), [[PATH]], [[Rockefeller Foundation]], [[Task Force for Global Health]], [[UKaid]], US [[Food and Drug Administration]], the [[United States Navy]], [[Unitaid]], [[University of Washington]], [[United States Agency for International Development]], [[Wellcome Trust]], and the [[World Health Organization]].((//Universities and Research Centres.// DNDi. Retrieved June 3, 2022, from https://archive.ph/Jsnj9)) ((//Non-profit Organizations and Networks.// DNDi. Retrieved June 3, 2022, from https://archive.ph/EY0c1)) ((//Ministries of Health and Governments.// DNDi. Retrieved June 3, 2022, from https://archive.ph/9wUBu))
 ===== Research =====
@@ Line 100: / Line 91: @@
 ==== SOLIDARITY Trial (2020-2022) ====
-Rees is the Co-Chair of the South African arm of the [[SOLIDARITY Trial]], the [[World Health Organization]]-sponsored study on repurposed drugs for use as [[COVID-19 treatments]]. The drugs under examination included [[hydroxychloroquine]], [[remdesivir]], and “[[antiviral drugs]] commonly used for [[HIV]].”
+Rees is the Co-Chair of the South African arm of the [[SOLIDARITY Trial]], the [[World Health Organization]]-sponsored study on repurposed drugs for use as [[COVID-19 treatments]].((WHO Solidarity Trial Consortium. (2020). //Repurposed antiviral drugs for COVID-19 — Interim WHO Solidarity Trial results.// New England Journal of Medicine. https://doi.org/10.1056/nejmoa2023184)) ((//#ListenToTheExperts Prof Helen Rees, Exec Director, Wits RHI tells us about the Solidarity Trial.// (2020, May 18). SA Corona Virus Online Portal. https://sacoronavirus.co.za/2020/05/18/listentotheexperts-prof-helen-rees-exec-director-wits-rhi-tells-us-about-the-solidarity-trial/)) The drugs under examination included [[hydroxychloroquine]], [[remdesivir]], and “[[antiviral drugs]] commonly used for [[HIV]].”((WHO Solidarity Trial Consortium. (2022). //Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.// The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(22)00519-0))
 ==== CROWN CORONATION Study (2020-2022) ====
-Rees is a Principal Investigator for the [[COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION]] (CROWN CORONATION) study, investigating strategies to protect healthcare workers against [[COVID-19]] infection. The study is sponsored by the [[COVID-19 Therapeutics Accelerator]], a funding initiative paid for by the [[Bill & Melinda Gates Foundation]], [[Mastercard]], [[Wellcome Trust]], the [[Government of the United Kingdom]], [[Madonna]], and the [[Chan Zuckerberg Initiative]], as well as pharmaceutical companies [[medical_technology_companies:BD]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[pharmaceutical_companies:bioMerieux]], [[pharmaceutical_companies:Eisai]], [[pharmaceutical_companies:Eli Lilly]], [[pharmaceutical_companies:Gilead Sciences]], [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Johnson & Johnson]], [[pharmaceutical_companies:Merck]] (both the US and German divisions), [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Pfizer]], and [[pharmaceutical_companies:Sanofi]].
+Rees is a Principal Investigator for the [[COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION]] (CROWN CORONATION) study, investigating strategies to protect healthcare workers against [[COVID-19]] infection.((Avidan, M., Washington University School of Medicine, & COVID-19 Therapeutics Accelerator. (2022, January 27). //An international, multi-site, Bayesian platform adaptive, randomized, placebo-controlled trial assessing the effectiveness of candidate agents in mitigating COVID-19 disease in adults.// ClinicalTrials.gov. https://archive.ph/Ploh3)) The study is sponsored by the [[COVID-19 Therapeutics Accelerator]], a funding initiative paid for by the [[Bill & Melinda Gates Foundation]], [[Mastercard]], [[Wellcome Trust]],((//COVID-19 Therapeutics Accelerator.// (2020, March 10). Bill & Melinda Gates Foundation. https://archive.ph/uXOjt)) ((Suzman, M. (2020, March 10). //Announcing the COVID-19 Therapeutics Accelerator.// Bill & Melinda Gates Foundation. https://archive.ph/Z8Q5l)) the [[Government of the United Kingdom]], [[Madonna]], and the [[Chan Zuckerberg Initiative]],((Au-Yeung, A. (2020, April 3). //A Bill Gates-backed accelerator for COVID-19 therapeutics treatment partners with Madonna and Mark Zuckerberg’s Chan Zuckerberg Initiative.// Forbes. https://archive.ph/WGnvO)) as well as pharmaceutical companies [[medical_technology_companies:BD]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[pharmaceutical_companies:bioMerieux]], [[pharmaceutical_companies:Eisai]], [[pharmaceutical_companies:Eli Lilly]], [[pharmaceutical_companies:Gilead Sciences]], [[pharmaceutical_companies:GlaxoSmithKline]], [[pharmaceutical_companies:Johnson & Johnson]], [[pharmaceutical_companies:Merck]] (both the US and German divisions), [[pharmaceutical_companies:Novartis]], [[pharmaceutical_companies:Pfizer]], and [[pharmaceutical_companies:Sanofi]].((Staines, R. (2020, March 26). //Pharma giants including Novartis collaborate on COVID-19 therapies.// Pharmaphorum; Pharmaphorum Media Limited. https://archive.ph/8TAzM))
 ==== Additional Funding ====
-Rees has received funding from the [[Bill & Melinda Gates Foundation]], [[Boston Consulting Group]], [[Mary Wohlford Foundation]], [[Microbicide Trials Network]], [[National Institutes of Health]], [[Public Health Institute]], [[United States Agency for International Development]] (USAID), and [[Wellcome Trust]].
+Rees has received funding from the [[Bill & Melinda Gates Foundation]], [[Boston Consulting Group]], [[Mary Wohlford Foundation]], [[Microbicide Trials Network]], [[National Institutes of Health]], [[Public Health Institute]], [[United States Agency for International Development]] (USAID), and [[Wellcome Trust]].((Rees, H. //Multipurpose Prevention Technologies: New drugs, New Delivery Systems.// South African HIV Clinicians Society. Retrieved June 5, 2022, from https://sahivsoc.org/Files/Fri_Helen_Rees%20Co-formulation%20HIV%20prevention%20and%20contraception.pdf))